Katie Shanahan and Bethany Weathersby Presented New Guidelines on HDFN at AABB 2025
Katie Shanahan, Research Consultant at the University of Pittsburgh, Director of Development at The Allo Hope Foundation, shared on LinkedIn:
”This weekend The Allo Hope Foundation was in San Diego at AABB!
Bethany and I presented new guidelines for the management of HDFN that will soon be published in major medical journals like JAMA and JACS.
Up until now, there have been no standardized, evidence based guidelines leading to inconsistent care and very preventable deaths.
These guidelines will save so many lives and I cannot believe that we are a part of them.
Even more importantly, I got to witness Bethany receive the AABB President’s Award for the work she has done and the countless lives she has saved.
She is one of the reasons my son Liam is alive and I couldn’t be more proud or honored to work with this warrior woman.
A huge thank you to Phil Spinella for his introduction into the AABB community and making the guidelines happen.
And also to the transfusion community and our industry partners for their engagement and passion for our patients and families.
Feeling so very grateful”
Stay updated with Hemostasis Today.
-
Dec 16, 2025, 16:34Mads Krogsgaard Thomsen on Novo Nordisk Haemophilia Foundation’s Support for Haemoglobinopathies
-
Dec 16, 2025, 16:22Leonardo Furtado Freitas Presents a Rare Hemorrhagic Hemangioblastoma Case
-
Dec 16, 2025, 16:14Nicolas Gendron on Sustainability in Anticoagulation and DOACs
-
Dec 16, 2025, 15:39Reza Shojaei: Every Expired Unit of Blood Tells a Story
-
Dec 16, 2025, 14:03Francesco Lo Monaco on Rethinking Blood Pressure: The Major Problem with How We Understand It
-
Dec 16, 2025, 14:03Marilena Vrana Urges EU Policymakers to “Keep Patients at the Centre” of Critical Medicines Act
-
Dec 16, 2025, 14:02Even Distribution of Protective Hemoglobin Prevents Sickle Cell Symptoms
-
Dec 16, 2025, 13:58AHA Awards Shubham Misra Postdoc Grant for LVO Stroke Biomarker Research
-
Dec 16, 2025, 13:00ScholarGPS Ranks Emmanuel J. Favaloro No. 1 in the World for Hemostasis